Search
Champions Oncology Inc
CSBRAdd to Watchlist
6.320USD
0.0000.00%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
87.76MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18No earnings forecast score is currently available for Champions Oncology Inc. The Biotechnology & Medical Research industry's average is 8.15. The average price target is 12.00, with a high of 12.00 and a low of 12.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Champions Oncology Inc's expected revenue for the next quarter?
Champions Oncology Inc's expected revenue is 12.89M.
What is Champions Oncology Inc's price target?
Analysts forecast that Champions Oncology Inc's price target is USD 12.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 12.00.
How have Champions Oncology IncCSBR's recent earnings per share performed?
The market expectation was USD -0.02, while Champions Oncology IncCSBR's earnings per share (EPS) for the previous quarter was USD 0.02. EPS for the next quarter is expected at USD -0.05.
